These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34956465)

  • 1. LangChuangHeJi decoction ameliorates lupus via preventing accumulation of CD138+ T cells in MRL/lpr mice.
    Xie T; Liu X; Liu H; Han X; Zhao J; Zhou D; Wang Y; Zhang H; Wang P; Li P
    Am J Transl Res; 2021; 13(11):12440-12460. PubMed ID: 34956465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid prevents CD138 expression in T cells of autoimmune MRL/
    Xie T; Liu H; Li P
    Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35514318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celastrol ameliorates lupus by promoting apoptosis of autoimmune T cells and preventing autoimmune response in MRL/lpr mice.
    Xie T; Rui H; Liu H; Liu X; Liu X; Li P
    Lupus Sci Med; 2024 Mar; 11(1):. PubMed ID: 38471722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD138 promotes the accumulation and activation of autoreactive T cells in autoimmune MRL/lpr mice.
    Xie T; Liu X; Li P
    Exp Ther Med; 2023 Dec; 26(6):568. PubMed ID: 37954119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus.
    Liu L; Takeda K; Akkoyunlu M
    Front Immunol; 2020; 11():1569. PubMed ID: 32849532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ANX A1 Antibody Therapy in MRL/lpr Murine Model of Systemic Lupus Erythematosus.
    Bradyanova S; Mihaylova N; Chipinski P; Manassiev Y; Herbáth M; Kyurkchiev D; Prechl J; Tchorbanov AI
    Arch Immunol Ther Exp (Warsz); 2021 Jul; 69(1):19. PubMed ID: 34322760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
    Yan SX; Deng XM; Wang QT; Sun XJ; Wei W
    Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating CD138 enhances disease progression by augmenting autoreactive antibody production in a mouse model of systemic lupus erythematosus.
    Liu L; Akkoyunlu M
    J Biol Chem; 2021 Sep; 297(3):101053. PubMed ID: 34364875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of CD40 siRNA on inflammatory response of MRL/Lpr mice].
    Wang ZH; Zhang W; Zhang YQ; Pang CY; Wang YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):771-776. PubMed ID: 27752154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
    Fujita Y; Fujii T; Mimori T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Tanaka M; Masaki Y; Fukushima T; Okazaki T; Umehara H
    J Immunol; 2014 Feb; 192(3):979-84. PubMed ID: 24391210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functional studies of adhesion molecules on CD4-CD8- double negative T cells of autoimmune MRL/Mp-lpr/mice].
    Wang W
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):755-66. PubMed ID: 8225181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
    Yang J; Li Q; Yang X; Li M
    Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.
    Moritoki M; Kadowaki T; Niki T; Nakano D; Soma G; Mori H; Kobara H; Masaki T; Kohno M; Hirashima M
    PLoS One; 2013; 8(4):e60807. PubMed ID: 23585851
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Nagasu A; Mukai T; Iseki M; Kawahara K; Tsuji S; Nagasu H; Ueki Y; Ishihara K; Kashihara N; Morita Y
    Cells; 2019 Apr; 8(5):. PubMed ID: 31052273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
    Zhang Z; Liu D; Zhang X; Wang X
    Inflammation; 2018 Oct; 41(5):1888-1899. PubMed ID: 29951872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD4- CD8- double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice.
    Merino R; Fossati L; Iwamoto M; Takahashi S; Lemoine R; Ibnou-Zekri N; Pugliatti L; Merino J; Izui S
    J Autoimmun; 1995 Feb; 8(1):33-45. PubMed ID: 7734035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice.
    Fujii T; Okada M; Fujita Y; Sato T; Tanaka M; Usui T; Umehara H; Mimori T
    J Autoimmun; 2009 Sep; 33(2):125-34. PubMed ID: 19596182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.